• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Neurology

FOCAL+ training program reduces the rate of collisions in teenage drivers with ADHD

byBryant LimandKiera Liblik
December 8, 2022
in Neurology, Pediatrics, Psychiatry, Public Health
Reading Time: 3 mins read
65% of alcohol-related childhood vehicular deaths related to riding with drunk drivers
Share on FacebookShare on Twitter

1. The Enhanced Focused Concentration and Attention Learning (FOCAL+) training program, compared to control FOCAL program, reduced the number of long glances and deviations in lane position among teenage drivers with attention deficit-hyperactivity disorder (ADHD). 

2. In real-world driving conditions monitored for one year, the participants in the FOCAL+ program had lower rates of long glances and collision or near-collision events.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Teenagers with ADHD have difficulty sustaining visual attention to the roadway and have twice the rate of collisions as non-ADHD teenagers. In the laboratory, these effects are characterized as long glances (≥ 2 seconds) from the roadway and deviations in lane position. The FOCAL program is a single-session, desktop-based program that trains neurotypical drivers to reduce long glances away from the roadway. The present randomized control trial compares the effectiveness of FOCAL control and FOCAL+ intervention programs for teenage drivers with ADHD. Participants were first trained over five sessions and subsequently followed for one year. During the simulated driving evaluations at both one and six months after training, teenagers in the intervention group had significantly fewer long glances away from the roadway and deviations of lane position compared to the control group. In the year following training, teenagers in the intervention group had significantly lower incidences of long glances, near-collisions, and collisions during abrupt changes in vehicle momentum compared to the control group. As a limitation, the study could not evaluate the effect of ADHD medication on collisions or near-collisions. The study was also unable to evaluate whether the intervention program would be effective without previous driving training, such as coursework and supervised driving.

Click to read the study in NEJM

In-Depth [retrospective cohort]: This randomized control trial compared the effectiveness of control FOCAL and intervention FOCAL+ driving training programs in drivers aged 16 to 19 with ADHD. Participants were randomized in a 1:1 ratio to receive FOCAL (n = 76) or FOCAL+ (n = 76) and followed for one year. The primary outcomes were the number of long glances (≥ 2 seconds) away from the roadway and lane deviations in map search tasks during 15-minute simulated drives at one and six months. The secondary outcomes were the rates of long glances away from the roadway and collision events during abrupt changes in vehicle momentum (g-force event) during the one-year of real-world driving. The mean number of long glances was significantly lower in the intervention group compared to the control group at one month (16.5 and 28.0, respectively; incidence rate ratio, 0.64; 95% Confidence Interval [CI], 0.52 to 0.76; p<0.001) and six months (15.7 and 27.0, respectively; incidence rate ratio 0.64; 95% CI, 0.52 to 0.76; p<0.001). The standard deviation (SD) of lane position was also significantly lower in the intervention group compared to the control group at six months (adjusted mean difference, -0.22 SD; 95% CI -0.31 to -0.13; p<0.001). During the one year of real-world driving, participants in the intervention group had fewer long glances during g-force events than those in the control group (relative risk, 0.76; 95% CI, 0.61 to 0.92). Motor vehicle near-collisions and collisions occurred during fewer g-force events in the intervention group compared to the control group (relative risk, 0.60; 95% CI, 0.41 to 0.89). These results suggest that a modified FOCAL+ training program may be effective in improving attention and reducing the rate of collisions in teenage drivers with ADHD.

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ADHDAdolescent ADHDAdolescent psychiatryAttention while drivingdrivingFOCALneurologypediatricspsychiatrypublic health
Previous Post

Buprenorphine in pregnancy is associated with lower neonatal risk than methadone

Next Post

Mental health needs remain unmet in homeless and recently housed individuals in Canada

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Next Post
Childhood maltreatment increases suicide risk

Mental health needs remain unmet in homeless and recently housed individuals in Canada

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Oral antibiotic prophylaxis may reduce incidence of surgical site infections

Combined MRI and NIH stroke scores may predict stroke prognosis

Maternal unintentional injury during pregnancy associated with higher risk of cerebral palsy

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.